Success cases
Prioritize translational work toward projects most likely to achieve market success
Roadmap for research lines developed at GutBioTox group led by Dr. Marta Arroyo
Challenge
A team of scientists develops personalized solutions to address xenobiotic-gut microbiota interactions, focusing on practical applications benefiting industry, consumers, and patients with gastrointestinal issues. The challenge lies in evaluating each solution´s feasibility, market readiness, and value proposition to effectively prioritize efforts and resources toward the projects with the strongest market potential.
Solution
Different business models were evaluated for each solution, with value propositions proposed. Market potential was assessed, and additional scientific or market data required to build a viable business case was identified. Competitor analysis provided insights into the competitive landscape, and a global overview prioritized the most promising lines, including relevant insights on potential competitors or similar solutions.
Result
The investigational lines were assessed for feasibility and readiness, and priority was assigned to the one closest to market readiness. The selected line demonstrated a competitive, secure dual business model with the added potential to extrapolate its know-how to other fields. This adaptability not only expands potential revenue streams but also positions the solution to evolve with changing market demands.
“Market potential was assessed, and additional scientific or market data required to build a viable business case was identified.”
Success case studies in the sector Biotech
success stories Strategic plan